Star Combo Pharma Limited

ASX:S66 Stock Report

Market Cap: AU$16.2m

Star Combo Pharma Past Earnings Performance

Past criteria checks 3/6

Star Combo Pharma's earnings have been declining at an average annual rate of -11.8%, while the Personal Products industry saw earnings growing at 9.3% annually. Revenues have been declining at an average rate of 1.7% per year. Star Combo Pharma's return on equity is 1.4%, and it has net margins of 1.9%.

Key information

-11.8%

Earnings growth rate

-0.8%

EPS growth rate

Personal Products Industry Growth-25.2%
Revenue growth rate-1.7%
Return on equity1.4%
Net Margin1.9%
Last Earnings Update31 Dec 2023

Recent past performance updates

Star Combo Pharma's (ASX:S66) Robust Earnings Might Be Weaker Than You Think

Mar 02
Star Combo Pharma's (ASX:S66) Robust Earnings Might Be Weaker Than You Think

Recent updates

Star Combo Pharma Limited's (ASX:S66) Shares May Have Run Too Fast Too Soon

Mar 20
Star Combo Pharma Limited's (ASX:S66) Shares May Have Run Too Fast Too Soon

Should Shareholders Have Second Thoughts About A Pay Rise For Star Combo Pharma Limited's (ASX:S66) CEO This Year?

Nov 21
Should Shareholders Have Second Thoughts About A Pay Rise For Star Combo Pharma Limited's (ASX:S66) CEO This Year?

Star Combo Pharma's (ASX:S66) Robust Earnings Might Be Weaker Than You Think

Mar 02
Star Combo Pharma's (ASX:S66) Robust Earnings Might Be Weaker Than You Think

Rock star Growth Puts Star Combo Pharma (ASX:S66) In A Position To Use Debt

Dec 24
Rock star Growth Puts Star Combo Pharma (ASX:S66) In A Position To Use Debt

Revenue & Expenses Breakdown
Beta

How Star Combo Pharma makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

ASX:S66 Revenue, expenses and earnings (AUD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Dec 2325040
30 Sep 2325-240
30 Jun 2325-440
31 Mar 2324-540
31 Dec 2223-540
30 Sep 2223-340
30 Jun 2223-150
31 Mar 2224-550
31 Dec 2124-850
30 Sep 2126-850
30 Jun 2127-850
31 Mar 2130-350
31 Dec 2033150
30 Sep 2036160
30 Jun 2039060
31 Mar 2038-160
31 Dec 1937-260
30 Sep 1929-260
30 Jun 1922-260
31 Mar 1917-270
31 Dec 1812-380
30 Sep 1812-270
30 Jun 1811-260
30 Jun 1710220
30 Jun 169210
30 Jun 157000
30 Jun 145000

Quality Earnings: S66 has high quality earnings.

Growing Profit Margin: S66 became profitable in the past.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: S66 has become profitable over the past 5 years, growing earnings by -11.8% per year.

Accelerating Growth: S66 has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.

Earnings vs Industry: S66 has become profitable in the last year, making it difficult to compare its past year earnings growth to the Personal Products industry (18%).


Return on Equity

High ROE: S66's Return on Equity (1.4%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.